title: Oral tranexamic acid as a novel treatment option for persistent haematuria in patients with sickle cell disease.
authors.forename: Niall F
authors.initials: NF
authors.lastname: Davis
authors.forename: Barry B
authors.initials: BB
authors.lastname: McGuire
authors.forename: Leo
authors.initials: L
authors.lastname: Lawlor
authors.forename: Peter
authors.initials: P
authors.lastname: O'Gorman
authors.forename: Kiaran J
authors.initials: KJ
authors.lastname: O'Malley
authors.forename: John M
authors.initials: JM
authors.lastname: Fitzpatrick
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000755:Anemia, Sickle Cell / Q000150:complications*; D000933:Antifibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006417:Hematuria / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D014148:Tranexamic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid